Common viral infections such as influenza and COVID-19 may accelerate the onset and progression of ALS, a new mouse study suggests.

For people with neuromuscular diseases at MDA Engage: Chicago, the biggest takeaway was realizing they are not alone.

Guest writer Cristy Hardin shares how defining friendship took on new meaning when she became a caregiver for a close friend.

Medicinova completed the last patient visit in the placebo-controlled portion of a trial testing MN-166, its experimental treatment for ALS.

Advocates are cheering as legislation to renew the ACT for ALS headed to President Trump's desk days before the program is set to expire.

A walk past fruit trees reminds columnist Kristin Neva of her father, and she thinks about what will remind her children of their dad.

Early rehabilitation and a care team that works together are crucial for helping people with neuromuscular disease stay active and safe.

Voice Back, an AI app, helps people with ALS and other causes of speech loss communicate using a voice that sounds like their own.

A progressive decline in lung function is unavoidable in ALS, but there are steps that patients can take to improve breathing issues.

Low muscle mass in the arms and legs and sarcopenia were linked to poorer survival in people with ALS in a small prospective study.

Phase 3 FUSION results suggest a targeted therapy may slow disease progression in FUS-ALS, with benefits seen versus placebo.

ALS disrupted her relationship with her body, so columnist Dagmar Munn developed small, intentional habits to restore her confidence.

Mouse model study finds molecular changes in inflammation, RNA, and protein processing before ALS symptoms appear.

ALS may change what marriage looks like for guest columnist Nancy Muirhead and her husband, but it cannot change their love.